Found: 54
Select item for more details and to access through your institution.
Oligomalt, a New Slowly Digestible Carbohydrate, Reduces Post-Prandial Glucose and Insulin Trajectories Compared to Maltodextrin across Different Population Characteristics: Double-Blind Randomized Controlled Trials in Healthy Individuals, People with Obesity, and People with Type 2 Diabetes
- Published in:
- Metabolites (2218-1989), 2024, v. 14, n. 8, p. 410, doi. 10.3390/metabo14080410
- By:
- Publication type:
- Article
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, n. 9, p. 2136, doi. 10.1093/ckj/sfab104
- By:
- Publication type:
- Article
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, p. 226, doi. 10.1093/ckj/sfaa225
- By:
- Publication type:
- Article
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
- Published in:
- Clinical Kidney Journal, 2020, v. 13, n. 4, p. 722, doi. 10.1093/ckj/sfz009
- By:
- Publication type:
- Article
Oligomalt, a New Slowly Digestible Carbohydrate, Is Well Tolerated in Healthy Young Men and Women at Intakes Up to 180 Gram per Day: A Randomized, Double-Blind, Crossover Trial.
- Published in:
- Nutrients, 2023, v. 15, n. 12, p. 2752, doi. 10.3390/nu15122752
- By:
- Publication type:
- Article
Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- letter
Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial.
- Published in:
- Diabetes Care, 2015, v. 38, n. 2, p. e15, doi. 10.2337/dc14-1684
- By:
- Publication type:
- Article
Altered Molecular Weight Forms of Adiponectin in Hypertension.
- Published in:
- Journal of Clinical Hypertension, 2009, v. 11, n. 1, p. 11, doi. 10.1111/j.1751-7176.2008.00057.x
- By:
- Publication type:
- Article
A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 4, p. 749, doi. 10.1007/s13300-023-01379-4
- By:
- Publication type:
- Article
Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 2, p. 863, doi. 10.1007/s13300-018-0385-5
- By:
- Publication type:
- Article
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, p. 1, doi. 10.1186/s12933-018-0682-3
- By:
- Publication type:
- Article
A randomised, active-and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-016-0493-3
- By:
- Publication type:
- Article
A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage.
- Published in:
- Frontiers in Aging, 2022, p. 1, doi. 10.3389/fragi.2022.852569
- By:
- Publication type:
- Article
Comparing aortic stiffness in kidney transplant recipients, hemodialysis patients, and patients with chronic renal failure.
- Published in:
- Clinical Transplantation, 2011, v. 25, n. 4, p. E463, doi. 10.1111/j.1399-0012.2011.01462.x
- By:
- Publication type:
- Article
Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 3, p. 579, doi. 10.1111/jdi.12746
- By:
- Publication type:
- Article
Pulsatile stress correlates with (micro-)albuminuria in renal transplant recipients.
- Published in:
- Transplant International, 2010, v. 23, n. 3, p. 292, doi. 10.1111/j.1432-2277.2009.00981.x
- By:
- Publication type:
- Article
Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2465, doi. 10.1111/dom.13829
- By:
- Publication type:
- Article
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA- T2D trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1610, doi. 10.1111/dom.13041
- By:
- Publication type:
- Article
Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-27648-7
- By:
- Publication type:
- Article
37-LB: Very-Low-Dose Premeal Whey Protein Microgels Reduce Postprandial (PP) Glucose in Type 2 Diabetes: A Randomized, Placebo-Controlled Crossover Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-37-LB
- By:
- Publication type:
- Article
132-LB: Implications of Initial EGFR Response to Empagliflozin Treatment Effects.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-132-LB
- By:
- Publication type:
- Article
432-P: Analyses of First plus Recurrent Cardiovascular and Hospitalization Events in the Cardiovascular and Renal Microvascular Outcome Study with Linagliptin (CARMELINA) in Patients with Type 2 Diabetes and Cardiorenal Disease.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-432-P
- By:
- Publication type:
- Article
388-P: Interrelationship between Hypoglycemia and CV and Mortality Outcomes in Type 2 Diabetes in the CARMELINA Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-388-P
- By:
- Publication type:
- Article
248-OR: Empagliflozin and Cardiorenal Outcomes in Patients with Nonproteinuric Kidney Disease in the EMPA-REG OUTCOME Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-248-OR
- By:
- Publication type:
- Article
Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA–T2D<sup>™</sup> trial.
- Published in:
- Diabetes & Vascular Disease Research, 2015, v. 12, n. 6, p. 455, doi. 10.1177/1479164115579002
- By:
- Publication type:
- Article
Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes & Vascular Disease Research, 2015, v. 12, n. 4, p. 249, doi. 10.1177/1479164115579001
- By:
- Publication type:
- Article
Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment.
- Published in:
- Diabetes & Vascular Disease Research, 2014, v. 11, n. 1, p. 34, doi. 10.1177/1479164113507068
- By:
- Publication type:
- Article
Non-Diabetic Chronic Kidney Disease Influences Retinal Microvasculature.
- Published in:
- Kidney & Blood Pressure Research, 2009, v. 32, n. 6, p. 428, doi. 10.1159/000264650
- By:
- Publication type:
- Article
Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes.
- Published in:
- Kidney International, 2014, v. 86, n. 5, p. 1057, doi. 10.1038/ki.2014.246
- By:
- Publication type:
- Article
Urinary Adiponectin Excretion.
- Published in:
- Diabetes, 2009, v. 58, n. 9, p. 2093, doi. 10.2337/db09-0204
- By:
- Publication type:
- Article
Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Letter to the editor regarding: 'Pharmacokinetics of teneligliptin in subjects with renal impairment.' Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 417, doi. 10.1002/cpdd.119
- By:
- Publication type:
- Article
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Linagliptin Lowers Albuminuria on Topof Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction.
- Published in:
- Diabetes Care, 2013, v. 36, n. 11, p. 3460, doi. 10.2337/dc13-0323
- By:
- Publication type:
- Article
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Long-Term Efficacy and Safety of Linagliptinin Patients With Type 2 Diabetes and Severe Renal Impairment.
- Published in:
- Diabetes Care, 2013, v. 36, n. 2, p. 237, doi. 10.2337/dc12-0706
- By:
- Publication type:
- Article
PPARγ Variant Influences Angiographic Outcome and 10-Year Cardiovascular Risk in Male Symptomatic Coronary Artery Disease Patients.
- Published in:
- Diabetes Care, 2009, v. 32, n. 6, p. e75, doi. 10.2337/dc09-0393
- By:
- Publication type:
- Article
Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays: response to Bluher et al.
- Published in:
- 2007
- By:
- Publication type:
- letter
Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays: response to Blüher et al.
- Published in:
- Diabetes Care, 2007, v. 30, n. 7, p. e67, doi. 10.2337/dc07-0398
- By:
- Publication type:
- Article
Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo.
- Published in:
- Diabetes Care, 2005, v. 28, n. 9, p. 2181, doi. 10.2337/diacare.28.9.2181
- By:
- Publication type:
- Article
SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes.
- Published in:
- 2005
- By:
- Publication type:
- clinical trial
Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia.
- Published in:
- Diabetes Care, 2004, v. 27, n. 12, p. 2925, doi. 10.2337/diacare.27.12.2925
- By:
- Publication type:
- Article
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 2, doi. 10.1186/1475-2840-13-28
- By:
- Publication type:
- Article
Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-60
- By:
- Publication type:
- Article